Fmoc-D-Nva-OH

Catalog No.: 
ACOIRC864
CAS No.: 
144701-24-6
Molecular Formula: 
C20H21NO4
Molecular Weight: 
339.39
Fmoc-D-Nva-OH structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g95%$77.00In stockIn stock
100g95%$269.00In stockIn stock
500g95%$940.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameFmoc-D-Nva-OH
IUPAC Name(R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)pentanoic acid
MDL No.MFCD00155640
Molecular FormulaC20H21NO4
Molecular Weight339.39
SMILESCCC[C@@H](NC(OCC1C2=C(C3=C1C=CC=C3)C=CC=C2)=O)C(O)=O
InChI KeyJBIJSEUVWWLFGV-GOSISDBHSA-N
Synonym(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)pentanoic acid | DS-3404 | CS-0101031 | MFCD00155640 | (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)pentanoic acid | Fmoc-D-norvaline | Fmoc-D-Nva-OH | DTXSID80373244 | SCHEMBL119530 | D-Norvaline, N-[(9H
CAS No.144701-24-6
PubChem CID2756112

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACOIRC864 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCVUE654 route compound structure diagram
    ACCVUE6542013-12-9In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOIRC864 route product structure diagram
    ACOIRC864144701-24-6In Stock
Inquiry

2. ACOIRC864 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOIRC864 route product structure diagram
    ACOIRC864144701-24-6In Stock
Inquiry

3. ACOIRC864 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOIRC864 route product structure diagram
    ACOIRC864144701-24-6In Stock
Inquiry

Comments (0)